Literature DB >> 31822935

The persistent potential of extracorporeal therapies in liver failure.

Valentin Fuhrmann1,2, Michael Bauer3, Alexander Wilmer4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31822935     DOI： 10.1007/s00134-019-05886-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  11 in total

1.  Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications.

Authors:  Katharina Staufer; Kevin Roedl; Danijel Kivaranovic; Andreas Drolz; Thomas Horvatits; Susanne Rasoul-Rockenschaub; Christian Zauner; Michael Trauner; Valentin Fuhrmann
Journal:  Liver Int       Date:  2017-04-05       Impact factor: 5.828

2.  American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease.

Authors:  Steven K Herrine; Paul Moayyedi; Robert S Brown; Yngve T Falck-Ytter
Journal:  Gastroenterology       Date:  2017-01-04       Impact factor: 22.682

3.  Visit to intensive care of 2050.

Authors:  Sharon Einav; Michael O'Connor; Luis Omar Chavez
Journal:  Intensive Care Med       Date:  2016-08-31       Impact factor: 17.440

4.  EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.

Authors:  Julia Wendon,; Juan Cordoba; Anil Dhawan; Fin Stolze Larsen; Michael Manns; Didier Samuel; Kenneth J Simpson; Ilan Yaron; Mauro Bernardi
Journal:  J Hepatol       Date:  2017-05       Impact factor: 25.083

5.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

Authors:  Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo
Journal:  Gastroenterology       Date:  2013-03-06       Impact factor: 22.682

Review 6.  Artificial and bioartificial liver devices: present and future.

Authors:  B Carpentier; A Gautier; C Legallais
Journal:  Gut       Date:  2009-12       Impact factor: 23.059

7.  Risk factors and outcomes of acute kidney injury in patients with acute liver failure.

Authors:  Shannan R Tujios; Linda S Hynan; Miguel A Vazquez; Anne M Larson; Emmanuel Seremba; Corron M Sanders; William M Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-11       Impact factor: 11.382

Review 8.  Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis.

Authors:  Yi Shen; Xu-Lin Wang; Bin Wang; Jian-Guo Shao; Yan-Mei Liu; Yan Qin; Lu-Jun Wang; Gang Qin
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

9.  Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit.

Authors:  Andreas Drolz; Thomas Horvatits; Kevin Roedl; Karoline Rutter; Katharina Staufer; Dominik G Haider; Christian Zauner; Gottfried Heinz; Peter Schellongowski; Stefan Kluge; Michael Trauner; Valentin Fuhrmann
Journal:  Ann Intensive Care       Date:  2016-07-08       Impact factor: 6.925

10.  Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP).

Authors:  Jean-Louis Vincent; Jean-Yves Lefrant; Katarzyna Kotfis; Rahul Nanchal; Ignacio Martin-Loeches; Xavier Wittebole; Samir G Sakka; Peter Pickkers; Rui Moreno; Yasser Sakr
Journal:  Intensive Care Med       Date:  2018-02-15       Impact factor: 17.440
View more
  1 in total

1.  A breakthrough trial of an artificial liver without systemic heparinization in hyperbilirubinemia beagle models.

Authors:  Yilin Wang; Shanshan Wang; Xueqin He; Yupei Li; Tao Xu; Lin Xu; Bo Yang; Xinnian Fan; Weifeng Zhao; Changsheng Zhao
Journal:  Bioact Mater       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.